This white paper discusses the supply chain strategies for COVID-19 vaccines, including purchasing, production, and distribution. With over 987 drugs and vaccines in development, pharmaceutical companies, CMOs, and suppliers are working to put in place a sound production and supply chain plan to ensure the vaccines reach people quickly and securely. However, there are uncertainties and variables that can impact production and distribution, such as the number of vaccines approved, the nature of the vaccine, and the number of vaccinations needed. The Pfizer and Moderna vaccines require special storage conditions, and the amount of vaccine needed depends on the population to be vaccinated and government policies. Overall, the success of the COVID-19 vaccine rollout will depend on effective supply chain management.
AI智能总结
